LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its Venezuelan operating affiliate, LataMed AI VE, will be featured in an interview in ES Salud Magazine, a healthcare-focused publication. The feature is expected to be published in the July 2026 edition and will include an editorial profile and interview discussing the Company’s healthcare technology initiatives, digital healthcare ecosystem strategy, and ongoing efforts to improve healthcare accessibility throughout Latin America.
The Company noted that it has received a formal invitation from the publisher to participate in a broader editorial feature package expected to include coverage through both ES Salud Magazine and Eva’s Magazine. According to the invitation, the feature is anticipated to be distributed through multiple print, digital, social media, and online publication channels. This expanded reach could significantly increase visibility for LataMed AI’s healthcare platform among healthcare professionals, industry participants, and other stakeholders.
Management stated that the publication provides an opportunity to discuss LataMed AI’s evolving healthcare platform while increasing visibility of the Company’s healthcare ecosystem. The feature is expected to discuss the Company’s telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven healthcare solutions currently under development.
The Company noted that the feature will highlight its broader vision of developing an integrated healthcare ecosystem designed to improve accessibility, coordination, and engagement for patients, healthcare providers, and other stakeholders across emerging markets. This aligns with the Company’s focus on addressing challenges in healthcare accessibility, coordination, and patient engagement that persist in many markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We appreciate the opportunity to share our vision for technology-enabled healthcare solutions and discuss the initiatives we are currently advancing throughout Latin America. We believe healthcare accessibility, coordination, and patient engagement remain important challenges across many markets, and we welcome opportunities to participate in industry discussions regarding the role of technology in addressing those challenges. We also believe opportunities to engage with healthcare-focused audiences help increase awareness of our broader healthcare ecosystem strategy and the technologies we are developing to support patients and providers throughout Latin America.”
The Company expects the feature to be published during July 2026 and intends to provide additional updates once publication details have been finalized, including information regarding publication dates, online availability, print distribution, and access through the publication's online digital channels. For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This feature represents a strategic move for LataMed AI to increase its profile in the healthcare industry, potentially attracting partners and investors interested in the intersection of technology and healthcare in emerging markets. As a development-stage company, such visibility is crucial for building credibility and advancing its initiatives.
